hsa_circ_0017842 acts as a competing endogenous RNA to enhance the malignancy of gastric cancer
Advances in Clinical and Experimental Medicine · 2023
DOI: 10.17219/acem/158484 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, 2023. Verfasst von Xigang Wen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Third People's Hospital of Hubei Province, Wuhan, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, MicroRNAs. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
BACKGROUND: Circular RNAs (circRNAs) have been shown to act as competing endogenous RNAs (ceRNAs) participating in the progression of gastric cancer (GC). OBJECTIVES: Our study aimed to investigate whether hsa_circ_0017842 can affect the malignancy of GC in a ceRNA manner. MATERIAL AND METHODS: Gene expression microarrays from GEO DataSets database, quantitative real-time polymerase chain reaction (qPCR) and western blotting were used to identify the expression levels of hsa_circ_0017842, miR-1294, and secreted protein, acidic and rich in cysteine (SPARC) in GC. The function of hsa_circ_0017842/miR-1294/SPARC axis in GC cells was confirmed using gainand loss-of-function assays. In addition, luciferase and RNA pulldown assays were performed to demonstrate the ceRNA mechanism of hsa_circ_0017842 involving miR-1294 and SPARC. RESULTS: The upregulation of hsa_circ_0017842 and SPARC, and downregulation of miR-1294 were observed in GC. Upregulating hsa_circ_0017842 in GC cells led to an increase in their proliferation, migration and invasion, and hsa_circ_0017842 knockdown showed the opposite effects on GC cells. Moreover, hsa_circ_0017842 was shown to be a sponge for miR-1294, thereby regulating SPARC expression. Due to the targeting relationship among hsa_circ_0017842, miR-1294 and SPARC, SPARC knockdown could relieve the effect of hsa_circ_0017842 overexpression on GC cells. CONCLUSIONS: Overall, this study confirmed that hsa_circ_0017842 acted as a ceRNA to promote the malignancy of GC cells through regulating the miR-1294/SPARC axis. Our findings might help better elucidate the molecular mechanism of GC tumorigenesis, and as a result improve the overall survival of GC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Third People's Hospital of Hubei Province, Wuhan, China.
- Department of Hospital Infection, Third People's Hospital of Hubei Province, Wuhan, China.
Zitieren
APA
Wen, X., Han, W., & Liu, C. (2023). hsa_circ_0017842 acts as a competing endogenous RNA to enhance the malignancy of gastric cancer. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/158484
Vancouver
Wen X, Han W, Liu C. hsa_circ_0017842 acts as a competing endogenous RNA to enhance the malignancy of gastric cancer. Advances in Clinical and Experimental Medicine. 2023. doi:10.17219/acem/158484
BibTeX
@article{Wen2023,
author = {Wen, Xigang and Han, Wenling and Liu, Chao},
title = {hsa_circ_0017842 acts as a competing endogenous RNA to enhance the malignancy of gastric cancer},
journal = {Advances in Clinical and Experimental Medicine},
year = {2023},
doi = {10.17219/acem/158484}
}
EUVIMED